Quantcast
Last updated on April 16, 2014 at 13:00 EDT

Latest multiple sclerosis Stories

2013-07-13 23:03:21

Natural Multiple Sclerosis Treatment created by Gary Levin is a new multiple sclerosis treatment book that reveals to people causes their MS, symptoms, signs, treatments and prevention. A full Natural Multiple Sclerosis Treatment overview on the site Vkool.com indicates if the book is worth buying. Seattle, Wa (PRWEB) July 13, 2013 Natural Multiple Sclerosis Treatment book introduces to people an effective multiple sclerosis treatment, tips, safe methods, natural remedies, diet plans, and...

2013-07-12 23:36:26

MSology, a free news service for people affected by multiple sclerosis (MS), is marking its first anniversary online with the launch of a new library of MS research. Montreal, Quebec (PRWEB) July 11, 2013 In its first year of operation, MSology (http://www.msology.ca) has greeted over 30,000 visitors from 181 countries. While articles are written in English, readers around the world are able to access the information with their search engine’s translation service. “There’s a...

2013-07-11 08:29:51

Tecfidera's High Early Physician Trial Rate Surpasses that Observed With Novartis's Gilenya and Genzyme's Aubagio, According to a New Report from BioTrends Research Group EXTON, Pa., July 11, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, despite being the third oral disease-modifying therapy (DMT) to launch in the U.S. multiple sclerosis (MS) market, 53 percent of surveyed...

2013-07-10 12:26:32

National Multiple Sclerosis Society's 29th Annual Southern Maine Ride Features Ocean Views and Routes for all Experience Levels BIDDEFORD, Maine, July 10, 2013 /PRNewswire/ -- A new start/finish venue and exciting new coastal routes are the centerpieces of the 29th Annual Bike MS: Great Maine Getaway to be held Aug. 10-11, 2013. Organized by the National Multiple Sclerosis Society, the ride is moving to the University of New England (UNE) in Biddeford. MS (multiple sclerosis), an...

2013-07-08 04:21:40

LONDON, July 8, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, is pleased to note the announcement from its partner Almirall S.A. that Sativex® is now available in Italy as a prescription medicine for use in the treatment of moderate to severe spasticity in Multiple Sclerosis (MS)...

2013-07-01 08:27:40

ALISO VIEJO, Calif., July 1, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced completion of patient enrollment in the company's phase II, placebo controlled study testing three doses of AVP-923 for the treatment of central neuropathic pain in multiple sclerosis. Top-line results from this study are expected in the fourth calendar quarter of 2013. (Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO) "Final completion of enrollment in...

2013-07-01 08:26:52

Nine pediatric MS centers across the country will benefit from continued Society investment NEW YORK, July 1, 2013 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society announced a new, three-year funding commitment of $2.5 million for the Network of Pediatric MS Centers (NPMSC) beginning July 1, 2013. Funding for the nine-center network provides essential infrastructure to facilitate research, including searching for the cause of MS by studying risk factors for the...

2013-06-17 08:26:28

Collaborative nonprofit to serve as "one-stop" source for information on MS services CHERRY HILL, N.J., June 17, 2013 /PRNewswire/ -- Today the Multiple Sclerosis Coalition (MSC) debuts new accounts on Facebook and Twitter that will serve as a "one-stop" source for information on available MS programs and services. Representing the leading organizations in MS research, advocacy, education, and treatment, the MSC will provide information on the individual offerings of member...

2013-06-13 12:28:48

-- Keynote Speaker, Rhonda R. Voskuhl, M.D., Director of the Multiple Sclerosis Program at UCLA, to Address the Role of Estriol in the Treatment of Multiple Sclerosis -- ROCKVILLE, Md., June 13, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, announced today that it will host a Multiple Sclerosis-Estriol Investor Day on Tuesday, June 25, 2013 from 9:00 a.m. to 11:00 a.m....

New Imaging Technique Could Help Speed Up Research For MS
2013-06-13 11:46:17

University of British Columbia Researchers at the University of British Columbia have developed a new magnetic resonance imaging (MRI) technique that detects the telltale signs of multiple sclerosis in finer detail than ever before — providing a more powerful tool for evaluating new treatments. The technique analyzes the frequency of electro-magnetic waves collected by an MRI scanner, instead of the size of those waves. Although analyzing the number of waves per second had long...